91 related articles for article (PubMed ID: 2763484)
21. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
22. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
24. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
Cortes J; Kantarjian H
Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047
[TBL] [Abstract][Full Text] [Related]
25. [Mixed myelodysplastic and myeloproliferative syndromes].
Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
[TBL] [Abstract][Full Text] [Related]
26. A myeloproliferative disorder may hide another one.
Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
[TBL] [Abstract][Full Text] [Related]
27. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
[TBL] [Abstract][Full Text] [Related]
28. Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias.
Spiers AS
Hematology; 2002 Feb; 7(1):1-8. PubMed ID: 12171771
[TBL] [Abstract][Full Text] [Related]
29. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
30. Endometrial extramedullary haemopoiesis.
Creagh TM; Bain BJ; Evans DJ; Reid CD; Young RH; Flanagan AM
J Pathol; 1995 May; 176(1):99-104. PubMed ID: 7616362
[TBL] [Abstract][Full Text] [Related]
31. The management of elderly patients with myeloproliferative disorders.
Tura S
Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
[No Abstract] [Full Text] [Related]
32. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
Vilcu A; Hossu T; Popescu ID; Câmpeanu L
Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
[No Abstract] [Full Text] [Related]
33. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
34. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations of chronic granulocytic leukemia.
Spiers AS
Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
[TBL] [Abstract][Full Text] [Related]
36. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
[No Abstract] [Full Text] [Related]
37. Acute myelofibrosis in children: report on two cases.
Maj JS; Rosłan K; Fic-Sikorska B
Acta Haematol Pol; 1996; 27(1):79-84. PubMed ID: 8629448
[TBL] [Abstract][Full Text] [Related]
38. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
[TBL] [Abstract][Full Text] [Related]
39. A chronic myeloid leukemia-like syndrome case with del (12) (p12) in a Li-Fraumeni syndrome family.
Guran S; Beyan C; Nevruz O; Yakicier C; Tunca Y
Clin Lab Haematol; 2005 Apr; 27(2):135-8. PubMed ID: 15784129
[TBL] [Abstract][Full Text] [Related]
40. [Syndrome of chronic intravascular coagulation in the course of chronic myeloid leukemia].
Rusinowska Z; Stella-Hołowiecka B
Wiad Lek; 1994 Jul; 47(13-14):544-6. PubMed ID: 7716945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
